Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The purinergic P2Y14 receptor links hepatocyte death to hepatic stellate cell activation and fibrogenesis in the liver
Ingmar Mederacke, Aveline Filliol, Silvia Affò, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 639
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Hepatic inflammatory responses in liver fibrosis
Linda Hammerich, Frank Tacke
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 10, pp. 633-646
Closed Access | Times Cited: 298
Understanding the cellular interactome of non-alcoholic fatty liver disease
Sebastian Wallace, Frank Tacke, Robert F. Schwabe, et al.
JHEP Reports (2022) Vol. 4, Iss. 8, pp. 100524-100524
Open Access | Times Cited: 81
Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH)
Shuang Wang, Scott L. Friedman
Science Translational Medicine (2023) Vol. 15, Iss. 716
Open Access | Times Cited: 52
Hepatic Stellate Cells: Dictating Outcome in Nonalcoholic Fatty Liver Disease
Leke Wiering, Pallavi Subramanian, Linda Hammerich
Cellular and Molecular Gastroenterology and Hepatology (2023) Vol. 15, Iss. 6, pp. 1277-1292
Open Access | Times Cited: 34
Liver Fibrosis: From Basic Science towards Clinical Progress, Focusing on the Central Role of Hepatic Stellate Cells
Hikmet Akkız, Robert K. Gieseler, Ali Canbay
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7873-7873
Open Access | Times Cited: 15
Multidimensional Interactive Cascading Nanochips for Detection of Multiple Liver Diseases via Precise Metabolite Profiling
Zhiyu Li, Weili Peng, Juan Zhou, et al.
Advanced Materials (2024) Vol. 36, Iss. 21
Closed Access | Times Cited: 10
A spatiotemporal atlas of cholestatic injury and repair in mice
Baihua Wu, Xinyi Shentu, Haitao Nan, et al.
Nature Genetics (2024) Vol. 56, Iss. 5, pp. 938-952
Closed Access | Times Cited: 10
Spatial genomics: mapping human steatotic liver disease
Kylie P. Matchett, J Paris, Sarah A. Teichmann, et al.
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 21, Iss. 9, pp. 646-660
Closed Access | Times Cited: 9
Targeting P2Y14R protects against necroptosis of intestinal epithelial cells through PKA/CREB/RIPK1 axis in ulcerative colitis
Chunxiao Liu, Hui Wang, Lu Han, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Metabolism of hepatic stellate cells in chronic liver diseases: emerging molecular and therapeutic interventions
Mengyao Yan, Cui Yi-min, Qian Xiang
Theranostics (2025) Vol. 15, Iss. 5, pp. 1715-1740
Open Access | Times Cited: 1
P2Y14R activation facilitates liver regeneration via CREB/DNMT3b/Dact-2/β-Catenin signals in acute liver failure
Mengze Zhou, Yehong Li, Jialong Qian, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access | Times Cited: 1
Small-molecule natural plants for reversing liver fibrosis based on modulation of hepatic stellate cells activation: An update
Yu Zheng, Long Xie, Dejun Yang, et al.
Phytomedicine (2023) Vol. 113, pp. 154721-154721
Closed Access | Times Cited: 17
Liver Fibrosis: From Basic Science to Clinical Progress
Hikmet Akkız, Robert K. Gieseler, Ali Canbay
(2024)
Open Access | Times Cited: 7
Inhibiting Liver Autophagy and Promoting Hepatocyte Apoptosis by Schistosoma japonicum Infection
Zhihao Yu, Tingting Jiang, Fangfang Xu, et al.
Tropical Medicine and Infectious Disease (2024) Vol. 9, Iss. 2, pp. 42-42
Open Access | Times Cited: 5
Hepatocyte programmed cell death: the trigger for inflammation and fibrosis in metabolic dysfunction-associated steatohepatitis
Zilu Cheng, Huikuan Chu, Ekihiro Seki, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 5
Efferocytosis in liver disease
Hongxue Shi, Mary P. Moore, Xiaobo Wang, et al.
JHEP Reports (2023) Vol. 6, Iss. 1, pp. 100960-100960
Open Access | Times Cited: 11
Qizhu Rougan Granules suppress liver fibrosis by inhibiting the expression of the P2Y14 receptor on hepatic stellate cells
Tao Yue, Qun Niu, Yuanqian Yao, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Harnessing the UDP-G/P2Y14R axis to promote liver regeneration in acute liver failure
Jian‐Hong Fang, Huichang Bi
Acta Pharmaceutica Sinica B (2025) Vol. 15, Iss. 2, pp. 1205-1206
Open Access
The Role of Yes‐Associated Protein in Inflammatory Diseases and Cancer
Bing Zhong, Jintao Du, Feng Liu, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access
FAP-catalyzed in situ self-assembly of magnetic resonance imaging probe for early and precise staging of liver fibrosis
Zhuoyao Wu, Weiwei Zeng, Weitao Yang, et al.
Science Advances (2025) Vol. 11, Iss. 11
Closed Access
Inflammation and cancer: molecular mechanisms and clinical consequences
Hikmet Akkız, Cem Şimşek, Deniz Balcı, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Preoperative donor urinary UDP-Glc as an independent risk factor for delayed graft function
Maolin Ma, Fei Han, Qianghua Leng, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Single-cell RNA sequencing advances in revealing the development and progression of MASH: the identifications and interactions of non-parenchymal cells
Ning Meng, Dong-Hui Lu, Liang Dong, et al.
Frontiers in Molecular Biosciences (2025) Vol. 12
Open Access
Metabolic reaction fluxes as amplifiers and buffers of risk alleles for coronary artery disease
Carles Foguet, Xilin Jiang, Scott C. Ritchie, et al.
Molecular Systems Biology (2025)
Open Access
Antifibrotic Therapies for Metabolic Dysfunction-associated Steatotic Liver Disease
Robert F. Schwabe, Frank Tacke, Atsushi Sugimoto, et al.
JHEP Reports (2025), pp. 101421-101421
Open Access
Page 1 - Next Page

Scroll to top